BACKGROUND: Cellular responses have been shown to play a role in immune control and clearance of West Nile virus (WNV) in murine models. However, little is known about the immunogenic regions of the virus or the phenotype of responding T cells in human infection. METHODS: Frozen peripheral blood mononuclear cells (PBMCs) from 35 WNV-infected blood donors were screened for virus-specific T cell responses by an interferon-gamma (IFN-gamma) enzyme-linked immunosorbent spot assay that used 452 overlapping peptides spanning all WNV proteins. More-detailed phenotypic studies were performed on subjects with high-magnitude T cell responses. RESULTS: In individuals with identified responses, the total number of recognized WNV peptides ranged from 1 to 9 (median, 2 peptides), and the overall magnitude of responses ranged from 50 to 4210 spot-forming cells (SFCs) per 10(6) PBMCs (median, 130 SFCs/10(6) PBMCs). A subset of 8 frequently recognized peptides from the regions of the genome encoding membrane, envelope, and nonstructural 3 and 4b proteins was identified. Phenotypic study of the highest magnitude WNV-specific T cell responses revealed that most were mediated by CD8+ cells that expressed perforin and/or granzyme B. CONCLUSIONS: These findings are the first to define the breadth and characteristics of the human T cell response to WNV and have implications for candidate vaccine design and evaluation.
BACKGROUND: Cellular responses have been shown to play a role in immune control and clearance of West Nile virus (WNV) in murine models. However, little is known about the immunogenic regions of the virus or the phenotype of responding T cells in humaninfection. METHODS: Frozen peripheral blood mononuclear cells (PBMCs) from 35 WNV-infected blood donors were screened for virus-specific T cell responses by an interferon-gamma (IFN-gamma) enzyme-linked immunosorbent spot assay that used 452 overlapping peptides spanning all WNV proteins. More-detailed phenotypic studies were performed on subjects with high-magnitude T cell responses. RESULTS: In individuals with identified responses, the total number of recognized WNV peptides ranged from 1 to 9 (median, 2 peptides), and the overall magnitude of responses ranged from 50 to 4210 spot-forming cells (SFCs) per 10(6) PBMCs (median, 130 SFCs/10(6) PBMCs). A subset of 8 frequently recognized peptides from the regions of the genome encoding membrane, envelope, and nonstructural 3 and 4b proteins was identified. Phenotypic study of the highest magnitude WNV-specific T cell responses revealed that most were mediated by CD8+ cells that expressed perforin and/or granzyme B. CONCLUSIONS: These findings are the first to define the breadth and characteristics of the human T cell response to WNV and have implications for candidate vaccine design and evaluation.
Authors: Qing Zhu; Colt Egelston; Susan Gagnon; Yongjun Sui; Igor M Belyakov; Dennis M Klinman; Jay A Berzofsky Journal: J Clin Invest Date: 2010-01-25 Impact factor: 14.808
Authors: Philip J Norris; Ken Schechtman; Heather C Inglis; Avril Adelman; John W Heitman; Ryan Vilardi; Avani Shah; Nareg H Roubinian; Ali Danesh; Anne M Guiltinan; Sheila M Keating; Jacques Lacroix; Mitchell J Cohen; Philip C Spinella Journal: Transfusion Date: 2019-03-18 Impact factor: 3.157
Authors: Marion C Lanteri; Tzong-Hae Lee; Li Wen; Zhanna Kaidarova; Marjorie D Bravo; Nancy E Kiely; Hany T Kamel; Leslie H Tobler; Philip J Norris; Michael P Busch Journal: Transfusion Date: 2014-06-26 Impact factor: 3.157
Authors: Philip C Spinella; Roman M Sniecinski; Felicia Trachtenberg; Heather C Inglis; Gayatri Ranganathan; John W Heitman; Fania Szlam; Ali Danesh; Mars Stone; Sheila M Keating; Jerrold H Levy; Susan F Assmann; Marie E Steiner; Allan Doctor; Philip J Norris Journal: Transfusion Date: 2019-03-05 Impact factor: 3.157
Authors: Amelia K Pinto; Justin M Richner; Elizabeth A Poore; Pradnya P Patil; Ian J Amanna; Mark K Slifka; Michael S Diamond Journal: J Virol Date: 2012-12-05 Impact factor: 5.103